Form 4 for TDOC Teladoc Health, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001477449-25-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-02-28 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | — | +6,081 | 33.6K | +22% | — |
| D | 2025-03-04 | 2025-03-03 | TDOC | Bliss Kelly | Pres, U.S. Group Health | S - Sale+OE | $9.68 | -2,904 | 35.4K | -8% | -$28.1K |
| DM | 2025-03-04 | 2025-02-28 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | $0.00 | -6,081 | 0 | -100% | $0 |
| D | 2025-03-04 | 2025-03-01 | TDOC | Bliss Kelly | Pres, U.S. Group Health | A - Grant | $0.00 | +109.8K | 109.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | M | A | 1,189 | — | 38,325 | D | — | — | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-03-03 | S | D | 2,904 | $9.68 | 35,421 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 3 | Common | Common Stock | 2025-02-28 | M | A | 3,488 | — | 37,136 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2025-02-28 | M | A | 1,404 | — | 33,648 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 3,488 | $0.00 | 13,952 | D | — · — to — | 3,488 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Performance Stock Units | 2025-02-28 | M | D | 1,189 | $0.00 | 4,753 | D | — · — to — | 1,189 Common Stock | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2025-03-01 | A | A | 109,832 | $0.00 | 109,832 | D | — · — to — | 109,832 Common Stock | (F7) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F8) One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 1,404 | $0.00 | 0 | D | — · — to — | 1,404 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |